August 17, 2017
UCB, a global pharmaceutical company, is partnering with Belgian American health startup Byteflies to use the startup's wearable sensors to monitor seizures.
Byteflies makes a customizable wearable device for the pharma and healthcare industries called Sensor Dot. It's a quarter-sized sensor that can be worn around the wrist or attached anywhere on the body as a patch. It's capable of measuring ...
May 8, 2017
Japanese health app maker Welby announced three new apps last month developed in partnership with pharma companies. Welby will add to its lineup three apps available only in Japan: an app for irritable bowel disease patients with Johnson & Johnson subsidiary Janssen; an app for pulmonary arterial hypertension (PAH) patients with Japanese pharma company Nippon Shinyaku, and an app for...
April 27, 2017
New York-based Fit4D, which offers digital coaching for people with diabetes, is partnering with global diabetes data management company Glooko to bring a more data-driven approach to their mobile patient engagement tools. The pairing will give Fit4D’s coaches access to Glooko’s device-agnostic platform, which people with diabetes see in the form of a mobile app they can use to automatically sync...
March 21, 2017
Teladoc has teamed up with Accolade, an on-demand healthcare concierge provider for employers, health plans and health systems, to help members navigate their telehealth benefits. The integrated service is now available to several of the two companies’ shared clients, and is showing increased utilization of Teladoc’s offerings: When a member is using the Accolade platform, the company’s Health...
March 20, 2017
Global pharmaceutical company UCB has launched Wellness4U, a health and wellness platform for people living with immunologic disorders which includes, as one aspect, an activity tracker pilot program.
"Our medicines treat thousands of people around the world and we are engaging with patients, their families and healthcare professionals to address their unmet needs," Todd Edwards, vice president...
January 5, 2017
Cambridge-based MC10, which makes paper-thin adhesive health sensors, and Belgium-based pharma company UCB have completed the Parkinson's study they began in 2014 and are aiming to publish the results later this year, the two companies announced.
The study used MC10's adhesive sensors to collect movement data on Parkinson's patients, combined with patient-reported outcomes and neurological...
June 24, 2015
A small study of veterans with epilepsy, conducted by PatientsLikeMe and sponsored by pharmaceutical company UCB, shows that an online patient community can increase self-efficacy and self-management of patients. The study was published in the journal Neurology.
A total of 92 patients enrolled in the study and completed a six-month follow up survey, while an additional 157 consented to...
September 16, 2014
Cambridge, Massachusetts-based MC10 announced former Broadcom executive, Scott Pomerantz has joined it as its new CEO and president, replacing David Icke, who is leaving the company. At semiconductor company, Broadcom, Pomerantz most recently served as the SVP and GM of wireless connectivity, Broadcom's biggest business. He joined Broadcom in 2007 after it acquired his GPS company, Global Locate...
July 28, 2014
Cambridge, Massachusetts-based flexible electronics company MC10 has embarked on its first public partnership with a pharmaceutical company, Belgium-based UCB. Although many of the details remain undisclosed, the companies have announced that UCB will use MC10's BioStamp technology to pursue new therapies for neurological disorders.
"They’re going to combine our devices with their work to...